Biogened S.A. (WSE:BGD)
30.60
-1.00 (-3.16%)
At close: May 21, 2025
Biogened Revenue
Biogened had revenue of 32.85M PLN in the quarter ending March 31, 2025, with 11.02% growth. This brings the company's revenue in the last twelve months to 114.20M, up 14.65% year-over-year. In the year 2024, Biogened had annual revenue of 110.94M with 16.09% growth.
Revenue (ttm)
114.20M
Revenue Growth
+14.65%
P/S Ratio
0.66
Revenue / Employee
514.40K
Employees
222
Market Cap
75.16M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 110.94M | 15.38M | 16.09% |
Dec 31, 2023 | 95.56M | 15.94M | 20.02% |
Dec 31, 2022 | 79.62M | 14.30M | 21.89% |
Dec 31, 2021 | 65.32M | 16.99M | 35.15% |
Dec 31, 2020 | 48.33M | 1.70M | 3.64% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Powszechna Kasa Oszczednosci Bank Polski Spólka Akcyjna | 28.10B |
Orlen | 286.18B |
Dino Polska | 29.96B |
Santander Bank Polska | 16.33B |
Powszechny Zaklad Ubezpieczen | 61.75B |
Bank Polska Kasa Opieki | 15.11B |
ING Bank Slaski | 9.90B |
Allegro.eu | 10.97B |